Stephen Bardin to Join atai Life Sciences as CFO Designate

Stephen Bardin will join as CFO Designate on June 27, 2022After a transition period, atai's current CFO Greg Weaver will be moving into a part time strategic advisory role NEW YORK and BERLIN, June

Related Keywords

Boston ,Massachusetts ,United States ,Berlin ,Germany ,Stephen Bardin ,Allan Malievsky ,Stanford Graduate School Of Business ,Company As Deputy ,Nasdaq ,Exchange Commission ,Halo Neuroscience Inc ,Myovant Sciences Inc ,Bio Pharma Inc ,Securities Exchange ,Boston Consulting Group ,Life Sciences ,Duke University ,Senior Vice President ,Bridgebio Pharma ,Chief Financial Officer ,Myovant Sciences ,Halo Neuroscience ,Boston Consulting ,Stanford Graduate School ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Annual Report ,Stephen ,Mardin ,Coin ,Tai ,Life ,Ciences ,Designate ,